Cerevel Therapeutics Holdings (CERE)
NASDAQ:CERE
US Market

Cerevel Therapeutics Holdings (CERE) Stock Price & Analysis

155 Followers

CERE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$19.59 - $35.98
Previous Close$22.73
Volume1.05M
Average Volume (3M)852.07K
Market Cap
$4.03B
Enterprise Value$3.66B
Total Cash (Recent Filing)$736.43M
Total Debt (Recent Filing)$369.13M
Price to Earnings (P/E)-8.9
Beta1.46
Nov 01, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.55
Shares Outstanding157,487,636
10 Day Avg. Volume1,510,471
30 Day Avg. Volume852,066
Standard Deviation0.23
R-Squared0.13
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)10.43
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-8.80
Forecast
Price Target Upside47.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

CERE FAQ

What was Cerevel Therapeutics Holdings’s price range in the past 12 months?
Cerevel Therapeutics Holdings lowest stock price was $19.59 and its highest was $35.98 in the past 12 months.
    What is Cerevel Therapeutics Holdings’s market cap?
    Currently, no data Available
    When is Cerevel Therapeutics Holdings’s upcoming earnings report date?
    Cerevel Therapeutics Holdings’s upcoming earnings report date is Nov 01, 2023 which is in 13 days.
      How were Cerevel Therapeutics Holdings’s earnings last quarter?
      Cerevel Therapeutics Holdings released its earnings results on Aug 02, 2023. The company reported -$0.63 earnings per share for the quarter, beating the consensus estimate of -$0.669 by $0.039.
        Is Cerevel Therapeutics Holdings overvalued?
        According to Wall Street analysts Cerevel Therapeutics Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Cerevel Therapeutics Holdings pay dividends?
          Cerevel Therapeutics Holdings does not currently pay dividends.
          What is Cerevel Therapeutics Holdings’s EPS estimate?
          Cerevel Therapeutics Holdings’s EPS estimate is -$0.63.
            How many shares outstanding does Cerevel Therapeutics Holdings have?
            Cerevel Therapeutics Holdings has 177,215,820 shares outstanding.
              What happened to Cerevel Therapeutics Holdings’s price movement after its last earnings report?
              Cerevel Therapeutics Holdings reported an EPS of -$0.63 in its last earnings report, beating expectations of -$0.669. Following the earnings report the stock price went down -14.095%.
                Which hedge fund is a major shareholder of Cerevel Therapeutics Holdings?
                Among the largest hedge funds holding Cerevel Therapeutics Holdings’s share is Perceptive Advisors LLC. It holds Cerevel Therapeutics Holdings’s shares valued at 315M.

                  ---

                  Cerevel Therapeutics Holdings Stock Smart Score

                  The Cerevel Therapeutics Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Cerevel Therapeutics Holdings

                  ARYA Sciences Acquisition Corp II is a blank check company.

                  ---

                  Top 5 ETFs holding CERE

                  Name
                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  $45.55M
                  8
                  Vanguard Health Care ETF
                  $4.73M
                  8
                  Vanguard Russell 3000 ETF
                  $84.88K
                  8
                  FlexShares Morningstar US Market Factor Tilt Index Fund
                  $67.87K
                  8
                  V-Shares US Leadership Diversity ETF
                  $46.38
                  8
                  Up to five ETFs with an Outperform Smart Score that hold CERE. The ETFs are listed according to market value of CERE within the ETF

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Sutro Biopharma
                  XBiotech
                  ACADIA Pharmaceuticals
                  Karuna Therapeutics

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis